A new drug, called orforglipron, can help people with diabetes manage their A1C and weight, according to topline results from ...

Imagine a world where managing type 2 diabetes doesn't involve needles. A new experimental pill might just change the game, ...

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...

Oral semaglutide cuts major heart risks in people with type 2 diabetes by 14%, offering a powerful pill-based option. Both ...

The drug helped lower patients’ blood sugar and reduce their weight by an average of 16 pounds.

People diagnosed with type 2 diabetes might benefit soon from Eli Lilly's new orforglipron weight loss drug following its ...

Eli Lilly said its phase 3 trial of GLP-1 drug in pill form found results similar to popular injectables for weight loss. Orforglipron would be used as a daily pill, eliminating the need for ...

The drugmaker Lilly announced topline results of a clinical trial of a new pill in the same drug class as injectables like Ozempic.

Countless investors and investment advisors are losing significant money because they are stuck in the orthodox thinking that ...

The global generic drugs market size has been calculated at $468.08 billion in 2025 and is estimated to be worth $728.64 ...

Other causes of colitis-like symptoms in people with diabetes include medication side effects, artificial sweeteners, or other medical diagnoses. UC is a type of inflammatory bowel disease (IBD ...

The market for anti-obesity drugs has been growing for a while, but is finally about to take off with the entry of two global ...